Apparatus for the transdermal treatment of Parkinson's disease
US6746688B1 · kind B1 · utility
38Cited by
9References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2000 |
| Grant date | Jun 8, 2004 |
| Priority date | — |
| Expiry date | Nov 13, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition for treatment of Parkinson's disease comprising a compound of levodopa dissolved in a non-degradative solvent which allows transdermal administrtion of levodopa. The compound of levodopa is an alkyl-ester of levodopa and the solvent is a formulation comprising a substantially non-aqueous solvent, a transdermal enchancer and a detergent. The alkyl-ester of levodopa is preferably levodopa-ethyl-ester (LDEE).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.